Pilulka Lekarny as Capital Reinvestment Ratio
Pilulka Lekarny as capital reinvestment ratio. Pilulka Lekarny as (PINK) has a Capital Reinvestment Ratio of 3.33x as of December 2021, meaning it reinvests 3% of its operating cash flow (Kč24.67 Million) in capital expenditures (Kč82.13 Million). See Pilulka Lekarny as free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pilulka Lekarny as (2020–2021)
Capital reinvestment ratio of Pilulka Lekarny as from 2020 to 2021. This chart tracks Pilulka Lekarny as's Capital Reinvestment Ratio across 2 annual periods. See PINK financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Pilulka Lekarny as Capital Reinvestment Ratio by Year (2020–2021)
Pilulka Lekarny as capital reinvestment ratio by year from 2020 to 2021. For the full cash flow conversion analysis, see Pilulka Lekarny as cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CZK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 3.33x | Kč24.67 Million | Kč82.13 Million | ▼ -11.0% |
| 2020 | 3.74x | Kč7.39 Million | Kč27.65 Million | — |